Fundamental analysis by اسمارت بورس about Stock دیران on 3/11/2021

#Delight Iran Drug Financial statements of the fiscal year ended 09/9/2019 (Audited) ️ ️ 125 % increase in operational revenues of 12 months compared to the same period (from 981,294 million rials to 2,203,331 million rials) ️ ️ 130 % GDP in 1399 compared to the same period (from 519,152 million rials to 1,195,479 million rials) ️ ️ Increasing 170 % Operational Profit of 1399 compared to the same period (from 440409 million rials to 1188721 million rials) ️ 211 % Net Profit Increase in 12 months 1399 and 1223 Rials per share (from 227756 million rials to 709082 million rials) Operational profit margins increased from 44.88% to 53.95% and net profit margin increased from 23.21% to 32.18%. @smart_investor ♌️